Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 668 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India

Prasanna Kumar K M, Mohan Viswanathan, Sethi Bipin, Gandhi Pramod, Bantwal Ganapathi, Xie John, Meininger Gary, Qiu Rong

Year : 2016| Volume: 20| Issue : 3 | Page no: 372-380

   This article has been cited by
 
1 Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study
Manash P Baruah,Sanjay Kalra
European Endocrinology. 2019; 15(2): 113
[Pubmed]  [Google Scholar] [DOI]
2 Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
Awadhesh Kumar Singh,Ambika G. Unnikrishnan,Abdul H. Zargar,Ajay Kumar,Ashok K. Das,Banshi Saboo,Binayak Sinha,Kalyan Kumar Gangopadhyay,Pradeep G. Talwalkar,Samit Ghosal,Sanjay Kalra,Shashank Joshi,Surendra Kumar Sharma,Usha Sriram,Viswanathan Mohan
Diabetes Therapy. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Long-Term Clinical Benefits of Canagliflozin 100 mg versus Sulfonylurea in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin in India
Vishal Gupta,Michael Willis,Pierre Johansen,Andreas Nilsson,Manan Shah,Amey Mane,Cheryl Neslusan
Value in Health Regional Issues. 2019; 18: 65
[Pubmed]  [Google Scholar] [DOI]
4 Canagliflozin: A Review in Type 2 Diabetes
Emma D. Deeks,André J. Scheen
Drugs. 2017; 77(14): 1577
[Pubmed]  [Google Scholar] [DOI]
5 Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants
Damayanthi Devineni,David Polidori,Christopher Curtin,Hans Stieltjes,Hong Tian,Ewa Wajs
Clinical Therapeutics. 2016; 38(1): 89
[Pubmed]  [Google Scholar] [DOI]

 

Read this article